Gastroesophageal reflux disease (GERD) is a common digestive disorder that affects the lower esophageal sphincter (LES), which is located at the end of the esophagus. The main cause of GERD is frequent backflow of stomach contents and digestive acids into the esophagus, causing discomfort like heartburn and acid regurgitation. Treatment devices for GERD include antacids, proton pump inhibitors, H2 blockers, devices like EndoCinch and magnetic sphincter augmentation systems. EndoCinch is an endoluminal gastroplication procedure for treatment of GERD without surgery. The procedure delivers radiofrequency energy to the lower esophageal tissue to create multiple plications or folds in the esophageal mucosa to prevent acid reflux. Magnetic sphincter augmentation systems like LINX Reflux Management System is a non-drug and non-surgical treatment option for GERD patients. The device is a collection of interlinked titanium beads with magnetic cores that are implanted around the LES to reinforce it.

The global Global Gastroesophageal Reflux Disease Treatment Devices Market Demand is estimated to be valued at US$ 450 Million in 2023 and is expected to exhibit a CAGR Of 11% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. The market is expected to be flourished by rising geriatric population globally as GERD is very common among the elderly.

Market Dynamics:

The market opportunity highlighted in the heading Gastroesophageal Reflux Disease Treatment Devices Market Poised to Expand Substantially due to Rising Geriatric Population is the growing geriatric population globally. With percentage of elderly people rising exponentially, the prevalence of GERD has increased significantly as well. For instance, 30-40% of U.S. adults experience GERD symptoms monthly and about 20% experience symptoms weekly according to a recent study published in Clinical Gastroenterology and Hepatology. Older adults are more prone to GERD due to factors like higher abdominal pressure, decreased functioning of the upper gastrointestinal tract, and lesser physical activity levels. Therefore, the increasing risk of GERD among geriatric population substantiates demand for innovative treatment devices and drives the market growth over the forecast period. Another major driver for this market is the surging preference for minimally invasive procedures over conventional medications and surger

Segment Analysis

The global gastroesophageal reflux disease treatment devices market is dominated by the bravo monitoring system sub segment. Bravo monitoring system helps in measuring the amount of acid reflux from the stomach to the esophagus over a period of 48 hours. It captures pH readings wirelessly through a catheter placed in the esophagus. The test is painless and allows patients to continue with their daily routine. This sub segment accounts for over 35% of the global market as bravo monitoring systems offer accurate diagnostic results with minimal patient discomfort.

PEST Analysis

Political: The market is positively impacted by favorable regulatory policies that encourage development of novel treatment options for GERD. Various governments are supporting research activities in this segment.

Economic: Rising geriatric population prone to GERD and growing healthcare spending are driving market growth. However, high cost of advanced devices may restrain the market to some extent.

Social: Growing awareness about various GERD treatment options and availability of new minimally invasive endoscopic procedures are supporting the market expansion. Sedentary lifestyles that contribute to obesity also increase the risk of GERD.

Technological: The market is witnessed significant technological advancements. New bravo monitoring systems and Endoscopic suturing devices offer better clinical outcomes compared to traditional treatment options. This is increasing adoption of advanced devices.

Key Takeaways

The Global Gastroesophageal Reflux Disease Treatment Devices Market Demand is expected to witness high growth.

North America region accounts for over 40% share primarily due to rising prevalence of GERD, availability of advanced devices and favorable reimbursement policies. The growing geriatric population suffering from GERD is a key factor fueling the North America market.
Europe market also holds a significant share and is projected to grow at a notable pace during the forecast period. Increasing awareness about minimally invasive treatment options and deployment of advanced healthcare infrastructure are promoting regional growth.

Key players operating in the gastroesophageal reflux disease treatment devices market are Medtronic, Johnson & Johnson, Torax Medical, EndoGastric Solutions. Medtronic is one of the leading players offering wide range of bravo monitoring systems and endoscopic suturing devices. The company has a strong global presence and clinical research capabilities.

Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it